Notícias e Atividades da Fujifilm Diosynth Biotechnologies

Fujifilm Diosynth Biotechnologies pertence à Fujifilm Holdings.

Fujifilm Holdings é uma das ...

• Forbes Global 2000 (#560);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Fujifilm Holdings é uma empresa listada sob o símbolo 4901 (JP).

Fujifilm Holdings tem presença direta em 10 países.

Fujifilm Holdings possui 18 subsidiárias incluindo Astra Graphia, Fujifilm e Fujifilm Business Innovation.

Eles estão dentro:

• Equipamento de Escritório26%
• Equipamentos Médicos16%
• Outro58%

Veja o organograma con seus 10 executivos principais

Biografias mais buscadas da Fujifilm Diosynth Biotechnologies

• Lars Petersen, President and Chief Executive Officer
• Toshi Iida, Chairman of the Board
• Gill Raw, General Counsel

Criar um alerta
para seguir os movimentos de executivos da Fujifilm Diosynth Biotechnologies.

Fujifilm Holdings possui 2.339 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Biogen (Estados Unidos).

Popular M&A news in Biotecnologia

• Jade Biosciences and Aerovate Therapeutics have announced they will merge  (publicado em 30 de abril de 2025)..
• Deepull acaba de anunciar uma arrecadação de fundos de 50 milhões de dólares. (publicado em 29 de abril de 2025).
• Biolinq acaba de anunciar uma arrecadação de fundos de 100 milhões de dólares. (publicado em 23 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Herriot Tabuteau - Chief Executive Officer and Director da Axsome Therapeutics
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Fujifilm Diosynth Biotechnologies

• FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement With TG Therapeutics - FUJIFILM Diosynth Biotechnologies
• FUJIFILM Diosynth Biotechnologies Launches First Phase of Global CDMO Ecosystem Expansion - FUJIFILM Diosynth Biotechnologies
• FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility - FUJIFILM Diosynth Biotechnologies
• Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina
• FUJIFILM Diosynth Biotechnologies Expands Manufacturing Agreement with Argenx for Efgartigimod for the Treatment of Severe Autoimmune Diseases
• FUJIFILM Diosynth Biotechnologies Appoints Richard McAvoy as Chief Financial Officer
• FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA with Better Energy for Denmark Manufacturing Site
• FUJIFILM Diosynth Biotechnologies and SHL Medical Enter strategic partnership agreement to help meet growing market demand for autoinjector medicines 
• Fujifilm to Invest USD 200 Million to Expand                                                         
• FUJIFILM Diosynth Biotechnologies Announces Leadership Succession Appointment Upon Retirement of Site Head
• View more press releases Close

Redes sociais sobre Fujifilm Diosynth Biotechnologies

• Fujifilm Diosynth Biotechnologies na Wikipedia, Google News e Yahoo Finance
• Fujifilm Diosynth Biotechnologies na LinkedIn, Twitter e YouTube